141 related articles for article (PubMed ID: 34365796)
1. Macropinocytosis-Inducible Extracellular Vesicles Modified with Antimicrobial Protein CAP18-Derived Cell-Penetrating Peptides for Efficient Intracellular Delivery.
Noguchi K; Obuki M; Sumi H; Klußmann M; Morimoto K; Nakai S; Hashimoto T; Fujiwara D; Fujii I; Yuba E; Takatani-Nakase T; Neundorf I; Nakase I
Mol Pharm; 2021 Sep; 18(9):3290-3301. PubMed ID: 34365796
[TBL] [Abstract][Full Text] [Related]
2. Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery.
Nakase I; Noguchi K; Aoki A; Takatani-Nakase T; Fujii I; Futaki S
Sci Rep; 2017 May; 7(1):1991. PubMed ID: 28512335
[TBL] [Abstract][Full Text] [Related]
3. Effects of Lyophilization of Arginine-rich Cell-penetrating Peptide-modified Extracellular Vesicles on Intracellular Delivery.
Noguchi K; Hirano M; Hashimoto T; Yuba E; Takatani-Nakase T; Nakase I
Anticancer Res; 2019 Dec; 39(12):6701-6709. PubMed ID: 31810935
[TBL] [Abstract][Full Text] [Related]
4. Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by macropinocytosis.
Nakase I; Noguchi K; Fujii I; Futaki S
Sci Rep; 2016 Oct; 6():34937. PubMed ID: 27748399
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Microvesicles Modified with Arginine-Rich Peptides for Active Macropinocytosis Induction and Delivery of Therapeutic Molecules.
Morimoto K; Ishitobi J; Noguchi K; Kira R; Kitayama Y; Goto Y; Fujiwara D; Michigami M; Harada A; Takatani-Nakase T; Fujii I; Futaki S; Kanada M; Nakase I
ACS Appl Mater Interfaces; 2024 Apr; 16(14):17069-17079. PubMed ID: 38563247
[TBL] [Abstract][Full Text] [Related]
6. Dodecaborate-Encapsulated Extracellular Vesicles with Modification of Cell-Penetrating Peptides for Enhancing Macropinocytotic Cellular Uptake and Biological Activity in Boron Neutron Capture Therapy.
Hirase S; Aoki A; Hattori Y; Morimoto K; Noguchi K; Fujii I; Takatani-Nakase T; Futaki S; Kirihata M; Nakase I
Mol Pharm; 2022 Apr; 19(4):1135-1145. PubMed ID: 35298163
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of rabbit CAP18-derived peptides.
Larrick JW; Hirata M; Shimomoura Y; Yoshida M; Zheng H; Zhong J; Wright SC
Antimicrob Agents Chemother; 1993 Dec; 37(12):2534-9. PubMed ID: 8109914
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of an analog of the antimicrobial peptide of LL‑37 on colon cancer cells via exosome‑encapsulated miRNAs.
Hayashi M; Kuroda K; Ihara K; Iwaya T; Isogai E
Int J Mol Med; 2018 Dec; 42(6):3009-3016. PubMed ID: 30221678
[TBL] [Abstract][Full Text] [Related]
10. Inkjet-Based Intracellular Delivery System that Effectively Utilizes Cell-Penetrating Peptides for Cytosolic Introduction of Biomacromolecules through the Cell Membrane.
Omura M; Morimoto K; Araki Y; Hirose H; Kawaguchi Y; Kitayama Y; Goto Y; Harada A; Fujii I; Takatani-Nakase T; Futaki S; Nakase I
ACS Appl Mater Interfaces; 2023 Oct; 15(41):47855-47865. PubMed ID: 37792057
[TBL] [Abstract][Full Text] [Related]
11. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.
Larrick JW; Hirata M; Balint RF; Lee J; Zhong J; Wright SC
Infect Immun; 1995 Apr; 63(4):1291-7. PubMed ID: 7890387
[TBL] [Abstract][Full Text] [Related]
12. Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates.
Grabeck J; Lützenburg T; Frommelt P; Neundorf I
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235193
[TBL] [Abstract][Full Text] [Related]
13. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
14. Structure and functions of endotoxin-binding peptides derived from CAP18.
Hirata M; Zhong J; Wright SC; Larrick JW
Prog Clin Biol Res; 1995; 392():317-26. PubMed ID: 8524937
[TBL] [Abstract][Full Text] [Related]
15. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
[TBL] [Abstract][Full Text] [Related]
16. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis.
Costa Verdera H; Gitz-Francois JJ; Schiffelers RM; Vader P
J Control Release; 2017 Nov; 266():100-108. PubMed ID: 28919558
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial properties of Latarcin 1 derived cell-penetrating peptides.
Budagavi DP; Chugh A
Eur J Pharm Sci; 2018 Mar; 115():43-49. PubMed ID: 29329747
[TBL] [Abstract][Full Text] [Related]
18. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity.
Hirata M; Shimomura Y; Yoshida M; Morgan JG; Palings I; Wilson D; Yen MH; Wright SC; Larrick JW
Infect Immun; 1994 Apr; 62(4):1421-6. PubMed ID: 8132348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
